Abstract
Increasingly recognized as bioactive molecules, sphingolipids have been studied in a variety of disease models. The impact of sphingolipids on cancer research facilitated the entry of sphingolipid analogues and enzyme modulators into clinical trials. Owing to its ability to regulate two bioactive sphingolipids, ceramide and sphingosine-1-phosphate, acid ceramidase (AC) emerges as an attractive target for drug development within the sphingolipid metabolic pathway. Indeed, there is extensive evidence supporting a pivotal role for AC in lipid metabolism and cancer biology. In this article, we review the current knowledge of the biochemical properties of AC, its relevance to tumor promotion, and its molecular targeting approaches.
Keywords: Ceramidase, sphingolipids, ceramide, sphingosine, cancer therapy
Current Drug Targets
Title: Molecular Targeting of Acid Ceramidase: Implications to Cancer Therapy
Volume: 9 Issue: 8
Author(s): Youssef H. Zeidan, Russell W. Jenkins, John B. Korman, Xiang Liu, Lina M. Obeid, James S. Norris and Yusuf A. Hannun
Affiliation:
Keywords: Ceramidase, sphingolipids, ceramide, sphingosine, cancer therapy
Abstract: Increasingly recognized as bioactive molecules, sphingolipids have been studied in a variety of disease models. The impact of sphingolipids on cancer research facilitated the entry of sphingolipid analogues and enzyme modulators into clinical trials. Owing to its ability to regulate two bioactive sphingolipids, ceramide and sphingosine-1-phosphate, acid ceramidase (AC) emerges as an attractive target for drug development within the sphingolipid metabolic pathway. Indeed, there is extensive evidence supporting a pivotal role for AC in lipid metabolism and cancer biology. In this article, we review the current knowledge of the biochemical properties of AC, its relevance to tumor promotion, and its molecular targeting approaches.
Export Options
About this article
Cite this article as:
Zeidan H. Youssef, Jenkins W. Russell, Korman B. John, Liu Xiang, Obeid M. Lina, Norris S. James and Hannun A. Yusuf, Molecular Targeting of Acid Ceramidase: Implications to Cancer Therapy, Current Drug Targets 2008; 9 (8) . https://dx.doi.org/10.2174/138945008785132358
DOI https://dx.doi.org/10.2174/138945008785132358 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunogenic Issues Concerning Recombinant Adeno-Associated Virus Vectors for Gene Therapy
Current Gene Therapy New Frontiers in Cystic Fibrosis Therapy: The Case of Stem Cells
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Significance of Oxidative Stress in Articular Cartilage Ageing and Degradation
Current Rheumatology Reviews Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials Importance of Pharmacology Knowledge by Dieticians
Current Nutrition & Food Science Recent Advances in Peroxisome Proliferator-Activated Receptor Science
Current Medicinal Chemistry Threes Company: Regulation of Cell Fate by Statins
Current Drug Targets - Cardiovascular & Hematological Disorders Insights into the Role of mTOR/AMPK as a Potential Target for Anticancer Therapy
Current Drug Therapy Targeting Stem Cells-Clinical Implications for Cancer Therapy
Current Stem Cell Research & Therapy Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Current Stem Cell Research & Therapy Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Cancer and Stem Cells
Current Cancer Therapy Reviews Monoclonal Antibodies in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Imaging Methods in Gene Therapy of Cancer
Current Gene Therapy Estrogen Receptor Expression and its Relevant Signaling Pathway in Prostate Cancer: A Target of Therapy
Current Molecular Pharmacology ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas
Current Cancer Drug Targets Serial Analysis of Gene Expression (SAGE): 13 Years of Application in Research
Current Pharmaceutical Biotechnology Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease
Current Topics in Medicinal Chemistry MAPKs as Mediators of Cell Fate Determination: an Approach to Neurodegenerative Diseases
Current Medicinal Chemistry Antiproliferative and Proapoptotic Effects of the TrK-inhibitor GW441756 in Human Myosarcomas and Prostatic Carcinoma
Current Signal Transduction Therapy